Cargando…
Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE
Although Transartial chemoembolization (TACE) is one of the recommended treatments for hepatocellular carcinoma (HCC), there is always a dispute on the selection of the best beneficiary for treatment. We studied the prognostic value of nutritional markers, obesity, visceral obesity and sarcopenia on...
Autores principales: | Li, Yuxuan, Hou, Juan, Chen, Rongfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328579/ https://www.ncbi.nlm.nih.gov/pubmed/37417609 http://dx.doi.org/10.1097/MD.0000000000034292 |
Ejemplares similares
-
Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017) -
Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma
por: Xie, Haixiang, et al.
Publicado: (2023) -
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib: A retrospective analysis
por: Dong, Dong, et al.
Publicado: (2022) -
High expression of HILPDA is an adverse prognostic prognostic factor in hepatocellular carcinoma
por: Wang, Xiao, et al.
Publicado: (2023) -
Exploring novel independent prognostic biomarkers for hepatocellular carcinoma based on TCGA and GEO databases
por: Hou, Miaomiao
Publicado: (2022)